Irish Pharmaceutical Healthcare Association

Lobbying Organisation Irish Pharmaceutical Healthcare Association

Date published 19 Jan, 2018

Relevant Matter Public policy or programme

Public Policy Area Health

Period 1 Sep, 2017 to 31 Dec, 2017

Specific Details Slowness in the reimbursement of new medicines in the Irish health system

Intended results To raise awareness among members of the Oireachtas that access to many new medicines in Ireland is slow and late

Name of person primarily responsible for lobbying on this activity Oliver O'Connor

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) Yes

Current or Former Designated Public Official(s)

Oliver O'Connor (Former DPO) Special Adviser (Department of Enterprise, Trade and Employment)

Oliver O'Connor (Former DPO) Special Adviser (Department of Health)

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Mass communications

Letter All Oireachtas Members This consisted of an IPHA policy document and a covering letter

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Letter (100+)

This consisted of an IPHA policy document and a covering letter

Designated public officials lobbied

There were no DPOs directly lobbied during this return period on this specific Subject Matter Area.